Generic drug industry needs to stand up for patient safety
from Los Angeles Times
The Generic Pharmaceutical Assn. says a proposed federal regulation that would allow makers of generic drugs to inform people about all known health risks would create "dangerous confusion" and have "harmful consequences for patients." And why would that be? For the answer, the industry group pointed me toward a recent report from Matrix Global Advisors, an independent consulting firm. The report says the rule change would needlessly complicate the market and add $4 billion a year to already bloated healthcare costs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063